Found: 6
Select item for more details and to access through your institution.
Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer.
- Published in:
- Molecular Cancer, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12943-020-01210-9
- By:
- Publication type:
- Article
The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 319, doi. 10.1007/s10549-022-06537-z
- By:
- Publication type:
- Article
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
DSCAM‐AS1 regulates the G<sub>1</sub>/S cell cycle transition and is an independent prognostic factor of poor survival in luminal breast cancer patients treated with endocrine therapy.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 12, p. 6137, doi. 10.1002/cam4.1603
- By:
- Publication type:
- Article